<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2623
  </number>
  <updateDate>
   2023-01-11T13:48:43Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:43Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-16
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 66 (Friday, April 16, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. GOTTHEIMER:H.R. 2623.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 1[Page H1891]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-19T16:41:44Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-16T13:04:20Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-16T13:04:15Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-04-19
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-16
    </actionDate>
    <text>
     Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-16
    </actionDate>
    <text>
     Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-16
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-16
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     G000583
    </bioguideId>
    <fullName>
     Rep. Gottheimer, Josh [D-NJ-5]
    </fullName>
    <firstName>
     Josh
    </firstName>
    <lastName>
     Gottheimer
    </lastName>
    <party>
     D
    </party>
    <state>
     NJ
    </state>
    <district>
     5
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     U000031
    </bioguideId>
    <fullName>
     Rep. Upton, Fred [R-MI-6]
    </fullName>
    <firstName>
     FRED
    </firstName>
    <lastName>
     UPTON
    </lastName>
    <party>
     R
    </party>
    <state>
     MI
    </state>
    <district>
     6
    </district>
    <sponsorshipDate>
     2021-04-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001298
    </bioguideId>
    <fullName>
     Rep. Bacon, Don [R-NE-2]
    </fullName>
    <firstName>
     Don
    </firstName>
    <lastName>
     Bacon
    </lastName>
    <party>
     R
    </party>
    <state>
     NE
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2022-01-06
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Taxation
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Business expenses
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Drug therapy
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      Income tax credits
     </name>
    </item>
    <item>
     <name>
      Medical research
     </name>
    </item>
    <item>
     <name>
      Medical tests and diagnostic methods
     </name>
    </item>
    <item>
     <name>
      Research and development
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Taxation
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-16
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-06-16T19:18:38Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Cameron's Law&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit). &lt;/p&gt; &lt;p&gt;The bill also requires the Centers for Disease Control and Prevention to complete a study to evaluate the feasibility of enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Cameron’s Law
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Cameron’s Law
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend the Internal Revenue Code of 1986 to restore the amount of the orphan drug tax credit, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Cameron’s Law
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-16T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2623ih/xml/BILLS-117hr2623ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-04-19
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-04-19
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-16
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-16
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-16
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-16
9
Library of Congress
Introduced in House
IntroReferral
2021-04-16T13:04:20Z
Referred to
House
Energy and Commerce Committee
2021-04-19T16:41:44Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
2021-04-16T13:04:15Z
Referred to
House
Ways and Means Committee
hswm00
Standing
U000031
6
FRED
Rep. Upton, Fred [R-MI-6]
UPTON
R
2021-04-16
MI
B001298
2
Don
Rep. Bacon, Don [R-NE-2]
Bacon
R
2022-01-06
NE
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-16
2021-04-19
Referred to the Subcommittee on Health.
House
Taxation
G000583
5
Josh
Rep. Gottheimer, Josh [D-NJ-5]
N
Gottheimer
D
NJ
Business expenses Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy Government studies and investigations Income tax credits Medical research Medical tests and diagnostic methods Research and development
2021-04-16
Introduced in House
 <p><b>Cameron's Law</b></p> <p>This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit). </p> <p>The bill also requires the Centers for Disease Control and Prevention to complete a study to evaluate the feasibility of enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.</p>
2021-06-16T19:18:38Z
00
2021-04-16T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2623ih/xml/BILLS-117hr2623ih.xml
Cameron’s Law
Cameron’s Law
Display Title
IH
Introduced in House
To amend the Internal Revenue Code of 1986 to restore the amount of the orphan drug tax credit, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Cameron’s Law
Short Title(s) as Introduced
HR
2023-01-11T13:48:43Z
2023-01-11T13:48:43Z
3.0.0
2021-04-19
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-16
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-16
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-16
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-16
9
Library of Congress
Introduced in House
IntroReferral
G000583
5
Josh
Rep. Gottheimer, Josh [D-NJ-5]
N
Gottheimer
D
NJ
U000031
6
FRED
Rep. Upton, Fred [R-MI-6]
UPTON
R
2021-04-16
MI
B001298
2
Don
Rep. Bacon, Don [R-NE-2]
Bacon
R
2022-01-06
NE
Business expenses Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy Government studies and investigations Income tax credits Medical research Medical tests and diagnostic methods Research and development
2021-04-16
Introduced in House
 <p><b>Cameron's Law</b></p> <p>This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit). </p> <p>The bill also requires the Centers for Disease Control and Prevention to complete a study to evaluate the feasibility of enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.</p>
2021-06-16T19:18:38Z
00
Cameron’s Law
Cameron’s Law
Display Title
IH
Introduced in House
To amend the Internal Revenue Code of 1986 to restore the amount of the orphan drug tax credit, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Cameron’s Law
Short Title(s) as Introduced
2021-04-19
Referred to the Subcommittee on Health.